Tamoxifen may increase risk of uterine sarcoma
نویسندگان
چکیده
منابع مشابه
Uterine sarcoma after tamoxifen therapy for breast cancer.
Tamoxifen has been shown to significantly reduce the risk of tumour recurrence in women with receptor positive breast cancer and has been used for chemoprevention in women with both non-invasive cancer and those with a high risk of developing breast cancer. An established and accepted risk with this treatment is the increased incidence of adenocarcinoma of the endometrium. Less well recognised ...
متن کاملUterine sarcoma
دقو .محرلا اموكراس نم نوناعي اضيرم 36 ضارعتسا تم :جئاتنلا دجو دقو ،اَماع 57 ةعومجملل رمعلا طسوتم نأ ريراقتلا تدافأ )19%(7 و carcinosarcoma تلاالحا نم )58%( 21 نأ اموكراس ةيمحللا محرلا ةناطب ،leiomyosarcoma )LMS( 6 يف تصخش )undifferentiated endometrial sarcom( .Rhabdomyosarcoma )RMS( 6% ينتلاحو 17% ىضرم ةثلاثلا ةلحرلما يف تصخش تلاالحا فصن براقي ام نأ دجو دقو يأ ةلاح 15( تناك ينح يف .يلاوتلا ىلع )...
متن کاملUterine sarcoma – current perspectives
Uterine sarcomas comprise a group of rare tumors with differing tumor biology, natural history and response to treatment. Diagnosis is often made following surgery for presumed benign disease. Currently, preoperative imaging does not reliably distinguish between benign leiomyomas and other malignant pathology. Uterine leiomyosarcoma is the most common sarcoma, but other subtypes include endomet...
متن کاملLong working hours may increase risk of coronary heart disease.
OBJECTIVE To evaluate the association between long working hours and risk of coronary heart disease (CHD) estimated by Framingham risk score (FRS) in Korean adults. METHODS This study evaluated adult participants in Korean National Health and Nutrition Examination Survey IV (2007-2009). After inclusion and exclusion criteria were applied, the final sample size for this study model was 8,350. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2002
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.325.7354.7/a